PG
ZNOV

Prostatis Group’s Innovator Equity Defined Protection ETF - 1 Yr November ZNOV Stock Holding History

Prostatis Group’s Portfolio ZNOV Stock Details ZNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
43,908
-3,630
-8% -$98.8K 0.28% 67
2026
Q1 		$1.26M Buy
47,538
+25,271
+113% +$676K 0.32% 69
2025
Q4 		$594K Buy
+22,267
New +$591K 0.14% 97

Other funds holding ZNOV

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
TWP
Triad Wealth Partners Lawrence, Kansas $1.7B AUM 21.07% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
ABWM
Alpine Bank Wealth Management Grand Junction, Colorado $779M AUM 19.75% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
LWA
Lineweaver Wealth Advisors Valley View, Ohio $845M AUM 20.71% 1-Year Est. Return

Prostatis Group's ZNOV Position: Q2 2026 in Review

Prostatis Group reduced its Innovator Equity Defined Protection ETF - 1 Yr November (ZNOV) stake by 7.6% in Q2 2026, selling an estimated $98.8K and leaving 43,908 shares worth $1.21M. The position accounts for 0.28% of the portfolio, ranked #67.

Prostatis Group first reported a position in ZNOV in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.26M in Q1 2026. 72 funds tracked by Wall St. Rank hold ZNOV as of Q2 2026.

  • Prostatis Group held 43,908 shares of Innovator Equity Defined Protection ETF - 1 Yr November worth $1.21M as of Q2 2026.
  • Prostatis Group sold 3,630 Innovator Equity Defined Protection ETF - 1 Yr November shares in Q2 2026, an estimated $98.8K.
  • Innovator Equity Defined Protection ETF - 1 Yr November made up 0.28% of Prostatis Group's portfolio in Q2 2026, its #67 holding.
  • Prostatis Group first reported a position in Innovator Equity Defined Protection ETF - 1 Yr November in Q4 2025 and has held it in 3 quarters since.
  • Prostatis Group's Innovator Equity Defined Protection ETF - 1 Yr November position peaked at $1.26M in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Innovator Equity Defined Protection ETF - 1 Yr November as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.